BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Younas M, Psomas C, Reynes C, Cezar R, Kundura L, Portalès P, Merle C, Atoui N, Fernandez C, Le Moing V, Barbuat C, Sotto A, Sabatier R, Winter A, Fabbro P, Vincent T, Reynes J, Corbeau P. Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy. Front Immunol 2021;12:663843. [PMID: 33859653 DOI: 10.3389/fimmu.2021.663843] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Pérez-gonzález A, Suárez-garcía I, Ocampo A, Poveda E. Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges. Microorganisms 2022;10:433. [DOI: 10.3390/microorganisms10020433] [Reference Citation Analysis]
2 Castillo-Mancilla JR, Musinguzi N, Asiimwe S, Siedner MJ, Orrell C, Bangsberg DR, Haberer JE. High residual inflammation despite HIV viral suppression: Lessons learned from real-time adherence monitoring among people with HIV in Africa. HIV Med 2021. [PMID: 34704355 DOI: 10.1111/hiv.13200] [Reference Citation Analysis]
3 Mohammad Yaseen M, Mohammad Abuharfeil N, Darmani H. T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein. Cellular Immunology 2022;377:104554. [DOI: 10.1016/j.cellimm.2022.104554] [Reference Citation Analysis]